This inventor holds 1 USPTO granted patent. Top assignee: Juno Therapeutics Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Brynn Olden: Inventor in Polymer-DNA Nanoparticle Stabilization
Introduction
Brynn Olden is an inventor associated with Seattle, Washington, and Juno Therapeutics GmbH. Olden is named on 1 patent concerning methods for controlling the size and activity of polymer-DNA nanoparticles.
Latest Patents
Olden’s patent, “Stabilization of Polyethyleneimine-Deoxyribonucleic Acid Complex Size and Activity,” describes methods for producing polymer-DNA nanoparticles with a predetermined size. The disclosed approach combines a DNA solution with a solution containing a cationic polymer to form a polyplex, then adds a stabilizing agent after a predetermined interval. Stabilizing the polyplex may help improve nanoparticle transfection efficacy, particularly in suspension cells used to produce viral vectors.
Career Highlights
Olden’s listed patent reflects work at the intersection of polymer chemistry and genetic-material delivery. The invention focuses on controlling polyplex size and activity, with potential relevance to processes involving viral-vector production.
Collaborations
The provided information identifies Robert Barnes and Elizabeth Larimore as Olden’s coworkers. It does not specify their roles in the patent or the invention.
Conclusion
Brynn Olden’s patent addresses a method for stabilizing polymer-DNA complexes, with the aim of improving their performance in applications such as viral-vector production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
